Evaluation of Symphony and Prodigy Devices for Blood Clot Removal in Peripheral and Pulmonary Vessels with Long-Term Safety Monitoring

What this Trial Is About

This research aims to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used to remove blood clots in the peripheral arteries, peripheral veins, and pulmonary vessels. The study includes patients undergoing endovascular procedures for arterial thromboembolism, venous thromboembolism, and pulmonary embolism, focusing on device use in these vascular areas. Participants are divided into three cohorts based on the blood vessel location peripheral arterial, peripheral venous, and pulmonary embolism. Each cohort undergoes aspiration thrombectomy using either the Symphony or Prodigy thrombectomy systems to remove clots. The study follows patients with the use of these devices in procedures planned within their intended use. Throughout the study, participants will be monitored at various time points including 30 days, 90 days, and 180 days after the procedure to assess device performance and safety. Follow-up includes evaluations of clinical outcomes related to clot removal. The total study period extends until September 2030, allowing for long-term observation of the devices effects.

Aspiration Thrombectomy Using the Symphony or Prodigy System